Economic uncertainty appears to have produced a wide variety of medtech earnings stories during the most recent round of quarterly results. Some medical device companies received massive boosts from their quarterly performance, while others saw their stocks sink amid missed projections and other various issues. The phrase “macroeconomic headwinds” was a common phrase. Medtech faces […]
ICU Medical
ICU Medical stock sinks on Q2 misses, slashed 2022 guidance
ICU Medical (Nasdaq:ICUI) shares took a hit on second-quarter results that came up shy of the consensus forecast. Shares of ICUI were down 6.4% at $176 per share before the market opened today. They had closed yesterday up 4.7% at $188.10 per share. The San Clemente, California-based company posted losses of $7.5 million, or 31¢ […]
ICU Medical reports a Street-beating Q1
ICU Medical (Nasdaq:ICUI) reported first-quarter results that came in ahead of the consensus earnings per share forecast. The San Clemente, California-based company yesterday evening posted losses of $38.1 million, or $1.61 per share, on sales of $543.1 million for the three months ended March 31, 2022, for a bottom-line slide into the red on sales growth […]
These 10 medtech companies’ stocks performed best in 2021
Following a year like no other in 2020, 2021 was when many looked to rebound — including the medtech industry. A number of medtech companies followed up a challenging, pandemic-enveloped year with impressive performances. Plenty of them had already proven in 2020 that they were capable of a quick bounce-back. Here are 10 medtech companies […]
ICU Medical beats The Street in Q4, posts full-year guidance
ICU Medical (NASDAQ:ICUI) shares rose today on fourth-quarter results that came in ahead of the consensus forecast. The San Clemente, California–based infusion therapy, oncology, and critical care tech company posted profits of $19.9 million, or 91¢ per share, on sales of $340.5 million for the three months ended Dec. 31, 2021, for a 23.8% bottom-line […]
ICU Medical completes $2.35B purchase of Smiths Medical
ICU Medical (NASDAQ:ICUI) recently announced that it has completed its $2.35 billion acquisition of Smiths Medical from the Smiths Group. Smiths Medical’s business includes syringe and ambulatory infusion devices, vascular access, and vital care products. The merger creates an infusion therapy company with estimated annual revenues of roughly $2.5 billion, ICU Medical said in a […]
ICU Medical’s Smiths Medical acquisition remains on track
ICU Medical (NASDAQ:ICUI) is a step closer to acquiring Smiths Medical after clearing a shareholders vote at Smiths’ British parent company, the Smiths Group. Almost all of the nearly 327 million Smiths Group shareholders voting on November 17 approved the $2.35 billion buy. Get the full story on our sister site Medical Tubing + Extrusion.
ICU Medical grows profits 24% in Q3 results
ICU Medical (NSDQ:ICUI) this week posted third-quarter results that beat the overall consensus on Wall Street. The San Clemente, California-based infusion therapy company reported profits of $31 million, or $1.43 per share, on sales of $336 million for the three months ended September 30, for a bottom-line gain of 24.4% on sales growth of 5.49% compared […]
ICU Medical reports 41% profit increase in Q1
ICU Medical (NSDQ:ICUI) posted first-quarter results yesterday that beat the overall consensus on Wall Street. The San Clemente, Calif.–based infusion therapy tech company reported profits of $23.7 million, or $1.09 per share, on sales of $318 million for the three months ended March 31, for a bottom-line gain of 41% on sales losses of -3.21% compared with […]
ICU Medical dips despite Street-beating Q4
ICU Medical (NSDQ:ICUI) shares took a slight hit today on fourth-quarter results that topped the consensus forecast. The San Clemente, Calif.–based infusion therapy and critical care technology developer posted profits of $26.1 million, or $1.21 per share, on sales of $320.5 million for the three months ended Dec. 31, 2020, for a 2.7% bottom-line gain […]
ICU Medical ticks up on Street-beating Q3, raised guidance
ICU Medical (NSDQ:ICUI) shares rose today on third-quarter results that came in ahead of the consensus forecast. The San Clemente, Calif.-based infusion therapy and critical care technology developer posted profits of $25 million, or $1.16 per share, on sales of $318.6 million for the three months ended Sept. 30, 2020, for a -5.9% bottom-line slide on […]